Biglycan (BGN) (Middle Region) Peptide
Quick Overview for Biglycan (BGN) (Middle Region) Peptide (ABIN8095558)
Target
Origin
Source
Application
-
-
Protein Region
- Middle Region
-
Purpose
- BGN Peptide - middle region
-
Sequence
- DTTLLDLQNN DISELRKDDF KGLQHLYALV LVNNKISKIH EKAFSPLRKL
-
-
Biglycan (BGN) peptide
BGN Reactivity: Human, Rat, Dog, Mouse Host: Synthetic BP, Imm
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti- BGN Antibody (ARP79418_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- Biglycan (BGN)
-
Background
-
Background Information: This gene encodes a member of the small leucine-rich proteoglycan (SLRP) family of proteins. The encoded preproprotein is proteolytically processed to generate the mature protein, which plays a role in bone growth, muscle development and regeneration, and collagen fibril assembly in multiple tissues. This protein may also regulate inflammation and innate immunity. Additionally, the encoded protein may contribute to atherosclerosis and aortic valve stenosis in human patients. This gene and the related gene decorin are thought to be the result of a gene duplication.
Alternative Symbols: PGI, MRLS, DSPG1, PG-S1, SEMDX, SLRR1A
-
Molecular Weight
- 42 kDa
-
Gene ID
- 633
-
NCBI Accession
- NP_001702
-
UniProt
- P21810
Target
-
